IL6 and rheumatoid arthritis: Recently, our group reported that GV1001 decreased the production of TNF-α, IL-1β, and IL-6 in peripheral blood mononuclear cells from rheumatoid arthritis patients through the suppression of p38 MAPK and NF-κB activation [51].